The independent source for health policy research, polling, and news.
661-680 of 780 results
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss health issues in the emerging tax bill, including the likely repeal of fines for those who fail to obtain health insurance. They also talk about the end of “open enrollment” for 2018 individual health insurance coverage.
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
The legalization of recreational marijuana in California and other states poses an added challenge for drug education programs targeting youths.
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
A battle brews as Republican Gov. Paul LePage says he won't implement the Medicaid expansion unless the Legislature funds Maine's share. Other states, such as Idaho and Utah, are keenly watching.
In Maine and Virginia, health care issues played on voters’ minds.
About 9 million people claimed about $87 billion in medical deductions in 2015.
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
The bipartisan accord would restore funding for the cost-sharing reductions that President Donald Trump ended last week and would give states more flexibility to devise alternatives for providing and subsidizing health care.
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
Many Californians have been using pot for years, legally and illegally. But newbies, even Grandma, might benefit from a website that contains warnings about the risks.
"If it gets signed by this governor, it's going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
Congress has yet to take substantive action on this growing consumer concern, but a number of states are flexing their cost-control muscle.
© 2026 KFF